In the case of non-melanoma cancers, a relatively larger cohort of patients with advanced epithelial tumors demonstrated a correlation between a higher abundance of muciniphila bacteria in their feces and more favorable responses to anti-PD-1 therapy 170. The gene discussed is PDCD1; the disease is melanoma.